Low-dose Interleukin-2 in the Treatment of Autoimmune Disease
Oncology & Hematology Review, 2014;10(2):157–63
Dr. Jeremy Abramson of Massachusetts General Hospital discusses mantle cell lymphoma (MCL). LRF Ambassador and MCL survivor, Bob Brixner, shares his story from diagnosis to remission.
Scientists at Cardiff University believe they have made a significant breakthrough in the treatment of the most prevalent strain of leukaemia. Chronic lymphocytic leukemia (CLL) affects 3,000...
This talk focuses on the very current robotic surgical techniques used for treating ovarian, endometrial and cervical cancers and its advantages and outcomes. Speaker: Amer Karam, MD, Associate...